the specific objectives of this funding opportunity are:

• to contribute to a reliable supply of highly qualified public health professionals able to respond to current and emerging public health problems across the country, including rural and northern communities.
• to provide special recognition and support to 世界杯2022赛程表淘汰赛 who are pursuing a master’s of public health degree in canada.
• to build capacity for effective knowledge translation and use of research evidence by the public health system working with other sectors.

interested applicants should contact the faculty of graduate studies for more information.

the amount of funding being allocated for research and development projects (“r & d projects”) in this funding round is $250,000.  each application is eligible to receive $25,000.

please also see the following guide and form.

substantially altered personal life styles and ongoing demographic change in many societies of modern industrialized countries have led to an increasing number of citizens who suffer from so-called common and complex diseases. particularly, when it comes to common diseases like cardiovascular, neurological/mental health or metabolic diseases, the resulting socioeconomic impact is immense. over the past several years, human genome research and related omics-approaches have led to a substantially improved knowledge in the field of common and complex human diseases. however, from this understanding it also has become clear that our current knowledge about the etiology and development of complex diseases on the cellular level needs to be extended by more context-related approaches.

in this respect, the newly developed field of health-oriented epigenomics provides a huge potential for a new and more context- and systems-oriented understanding of the cellular regulation in health and disease. epigenetics deals with the highly complex mechanisms within our cells that regulate the activity of our genes. given the highly specialised function of most of our cells, only a limited number of genes - in a context dependent manner - are switched on in a certain cell type and under certain conditions. this activation is highly regulated by epigenetic processes which can confer information brought about by external factors such as environmental impacts, nutrition or cellular stress. epigenomics is the high-throughput research approach which investigates a wide range of epigenetic factors on a general, systematic level. epigenomics is a demanding field, both in terms of research infrastructure and scientific expertise. a substantially improved understanding of human epigenetic mechanisms and processes that lead to common and complex diseases will pave the way for novel approaches in prevention, diagnosis and therapy.

as a result of the level of complexity, epigenomics calls for international cooperation that can pool resources and generate "critical masses" of research capacities and competencies. the agence nationale de la recherche (anr), the bundesministerium für bildung und forschung (bmbf) and the canadian institutes of health research (cihr) together with the fonds de recherche du québec - santé (frqs), decided to join forces in a multilateral joint transnational call for proposals to support epigenomics of common and complex diseases. the aim of this joint call is to promote and create strategic synergy and multidisciplinary research activities between scientists in france, germany and canada at a high level. the multilateral joint transnational call will foster the identification and characterization of epigenomic mechanisms relevant for complex diseases and open new routes for prevention, diagnosis and therapy. the multilateral joint transnational call will be published on the french national research agency website.

funds available

cihr and partner(s) financial contributions for this initiative are subject to availability of funds. should cihr or partner(s) funding levels not be available or are decreased due to unforeseen circumstances, cihr and partner(s) reserve the right to reduce, defer or suspend financial contributions to grants received as a result of this funding opportunity.

• each funding partner will fund the research component performed by researchers associated with institutions within their respective jurisdiction, according to their standard terms and conditions. the total amount available for canadian funds in this funding opportunity call are: cihr ca$2,300,000, frqs ca$500,000, enough to fund approximately 4-6 teams.
• the maximum amount for the research component performed and supported in canada, per team, is $200,000/year for up to 3 years (i.e., $600,000 total over 3 years). of this amount, the maximum contribution per team for frqs in canada is $250,000 over 3 years.

the specific objectives of this funding opportunity are:

• to support interdisciplinary programmatic research that improves our understanding of how environment-gene interactions or environment-microbiome-gene interactions contribute to both metabolic and immunologically-mediated non-communicable chronic diseases;
• to support interdisciplinary programmatic research on the etiology of chronic non-communicable disease that may ultimately contribute to the development of new intellectual property, research methodology (including new methods for measuring environmental exposures) and/or approaches for disease prevention or treatment; and
• to build interdisciplinary collaborations and foster canadian expertise in order to elucidate the environmental and genetic origins of non-communicable chronic disease.

the sharing big data for health care innovation: advancing the objectives of the global alliance for genomics and health competition aims to support a single pan-canadian program to develop a comprehensive strategy that will enable the sharing of genomic and clinical datasets across canada and around the globe in a responsible, secure and effective manner, thereby accelerating progress in health research and improving patient care.

it is expected that the program will leverage existing provincial and national genomic and clinical data sharing efforts and be aligned with international initiatives.

in order to meet the objectives of the competition the program must:

• be pan-canadian, that is, must include applicants from at least three different provinces/territories;
• involve a broad range of stakeholders, including for example researchers, clinicians, bioinformaticians/computational biologists, ge³ls¹ scholars, policy makers, patient/disease groups, and industry;
• support the activities of the global alliance and one or more of its working groups to ensure interoperability and alignment with international efforts;
• engage with relevant provincial, national and international organizations and initiatives interested in working together to address the challenges of data sharing, many of which may be members of the global alliance;
• propose pilot/demonstration projects that validate the utility and possible adoption of the strategy within canada, as well as a mechanism to identify additional projects as the program develops;
• present an integrated translation plan that engages data stewards and end-users to facilitate the implementation of the program; and,
• have an appropriate management structure.

the program must include activities focused on one or more of the topics being advanced by the global alliance, including but not limited to the following:

• development of interoperable guidelines and ethical frameworks for data sharing;
• establishment of data standards and improved methods for analyzing and storing large data sets that can be shared nationally and internationally including application programming interfaces;
• creation of a technology environment that provides patients, researchers, clinicians and other stakeholders assurance that genomic and clinical data are being accessed, annotated, and interpreted in a secure manner adhering to privacy policies; and/or,
• development of standards for representing phenotypic data and linking it to genotypic information that are in line with international standards in the area.

the proof of principle (pop) phase ii program provides funding for proof of principle research projects up to 12 months in duration at the co-investment stage undertaking follow-on proof of principle activities in partnership with a non-academic investor. this funding opportunity is aimed at providing a platform to better enable the academic institution/researcher to move the discovery/invention further down the innovation pipeline. research projects across all four pillars of cihr are eligible for this program. note that the end product is not required to generate revenue, but there must be a demonstrated market and opportunity for your product.

• in order for a research project to be appropriate for pop phase ii, the research should be at the stage where:
  • the principle of the intellectual property (ip) has already been proven;
  • the applicants have acquired interest from partners willing to invest in the new technology.

the proof of principle (pop) phase i program provides funding for proof of principle research projects of up to 12 months duration designed to advance discoveries/inventions towards commercializable technologies, with a view to attract new investment, create new science-based businesses, organizations and initiatives, and ultimately improve health outcomes for canadians. research projects across all four pillars of cihr are eligible for this program. note that the end product is not required to generate revenue, but there must be a demonstrated market and opportunity for your product. applications for the continuation of a research project funded through the pop phase i grant must progress from phase i to phase ii.

in order for a research project to be appropriate for pop phase i, the research should be at the stage where:

• the intellectual property (ip) that needs to be protected (or is protected) has been identified and described;
• the product/process/service, and what will be commercialized have been identified;
• the ip has been subjected to an initial technology assessment.

the goal of the proof of principle program is to facilitate and improve the translation of knowledge and technology resulting from academic health research for the benefit of canadians.

the specific objectives of this funding opportunity are to:

• provide the opportunity to determine the potential for commercial viability and other opportunities for use of ip;
• provide the opportunity to enhance and strengthen the value of ip (or ip portfolio);
• improve the institution and/or researcher’s business prospects and potential for downstream investments on the ip;
• promote academic health research and technology transfer activities that support and accelerate commercialization of ip;
• foster an entrepreneurial culture within and around the health research community in canada;
• promote economic development through health research in canada;
• support the application of health research results to improve the health of canadians.

faculty members considering an application to the pop phase i program are asked to contact the edi office far in advance of the deadline.

through the institute community support (ics) program, the cihr institutes are launching the ics travel awards competition for 世界杯2022赛程表淘汰赛 , postdoctoral fellows, new investigators and knowledge users to present their own research at national and international meetings and/or conferences.

the specific objectives of this funding opportunity are:

• to support planning activities, partnership development and/or increasing understanding of the health research landscape that will contribute to the advancement of research consistent with the mandate of cihr; and/or;
• to support dissemination events/activities that focus on the communication of health research evidence to the appropriate researcher and/or knowledge user audience(s), tailoring the message and medium as appropriate.

relevant research areas

events/activities may focus on, but are not limited to, the following:

planning:

• activities that assist potential teams of researchers, knowledge-users and/or partners in working together to identify research questions or emerging issues and priorities that could form the basis of a grant application;
• stakeholder consultations, including citizen engagement activities, regarding needs, gaps and opportunities in the health research landscape, priority policy issues and/or priority research questions, where such common understanding is currently lacking or requires further development;
• initial planning and discussion of a research project among potential team members including researchers, knowledge-users and/or partners to assess the viability of the research project and the partnership;
• conducting an environmental scan or preliminary synthesis of relevant literature, activities or programs;
• early-stage planning to determine possible commercial viability of a discovery;
• opportunities for knowledge exchange involving stakeholder linkages (to inform practice, care, and/or policy) that could potentially lead to an application to a funding opportunity;
• gatherings of partners, health researchers, and/or knowledge users where the main objective is to facilitate regional/national and/or international collaboration among individuals or groups from a variety of backgrounds (for example, building new and existing multi-sectored partnerships that include a significant number of participants from outside the conventional scientific community, consensus meetings, networking and partnership development events) interested in applying to a funding opportunity.

dissemination:

• education of groups such as patients, health professionals, community organizations, policy-makers, the general public;
• knowledge dissemination that will inform practice, clinical care, partnership best practices, policy and decision making;
• dissemination and/or discussion of research findings at scientific meetings, workshops, conferences, congresses or symposia;
• development and dissemination of kt products and tools (e.g., written materials in various formats, plain language summaries, decision support tools, educational materials, web sites).

the specific objectives of this funding opportunity are:

• encourage and facilitate mutually beneficial university*-industry collaborations in health research;
• stimulate the health research activities of private sector companies in canada;
• build capacity of researchers and trainees through interaction with industry;
• enhance communications between industry and universities;
• foster an entrepreneurial culture within and around the health research community in canada;
• promote economic development through health research in canada;
• support the application of health research results to improve the health of canadians.